REGULATORY INTELLIGENCE·Recall
Novocol Pharmaceutical's Mepivacaine Hydrochloride Recall: Label Mix-Up Exposes Critical Supply Chain Vulnerabilities
Novocol Pharmaceutical of Canada, Inc. initiated a Class III recall of 15,398 cartridges of Scandonest 3% Plain (Mepivacaine Hydrochloride) due to a label mix-up. This voluntary action, impacting U.S. distribution, underscores critical quality control vulnerabilities for procurement and regulatory teams. The terminated recall highlights the imperative for robust supplier oversight and stringent labeling verification to mitigate supply chain disruption and patient safety risks.
90-Day Activity